…
Jackson Acquisition Company II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2024 and is based in Alpharetta, Georgia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Jackson Acquisition Company II is a special purpose acquisition company created to raise IPO capital and complete a merger or business combination. Its long-term prospects depend on sourcing a suitable target, favorable dealmaking conditions and sponsor execution; investors may find access to a pre-deal equity opportunity and cash-in-trust downside protection attractive.
Principal risks include the uncertainty and timing of completing a combination, dilution from sponsor economics and PIPE financing, shareholder redemptions and market or regulatory changes that could erode deal value.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 |
| Income before tax | 9.12M | 0.38M |
| Net income | 9.12M | 0.38M |
| Selling general administrative | 0.57M | - |
| Ebitda | -0.57M | 0.38M |
| Operating income | -0.57M | -0.18M |
| Other operating expenses | 0.57M | 0.18M |
| Interest income | 9.68M | - |
| Net interest income | 9.68M | - |
| Total revenue | 0.00M | - |
| Total operating expenses | 0.57M | 0.18M |
| Total other income expense net | 9.68M | 0.56M |
| Net income from continuing ops | 9.12M | - |
| Breakdown | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 |
| Total assets | 243.18M | 234.01M |
| Other current assets | 0.11M | 0.11M |
| Total liab | 0.41M | 0.36M |
| Total stockholder equity | 242.76M | 233.65M |
| Other current liab | 0.13M | 0.10M |
| Common stock | 242.54M | 232.86M |
| Capital stock | 242.54M | 232.86M |
| Retained earnings | 0.22M | 0.38M |
| Cash | 0.52M | 0.95M |
| Total current liabilities | 0.41M | 0.36M |
| Net debt | -0.32M | -0.75M |
| Short term debt | 0.20M | 0.20M |
| Short long term debt | 0.20M | 0.20M |
| Short long term debt total | 0.20M | 0.20M |
| Other stockholder equity | - | 0.41M |
| Total current assets | 0.63M | 1.06M |
| Accounts payable | 0.09M | 0.06M |
| Non currrent assets other | 242.54M | 0.08M |
| Non current assets total | 242.54M | 232.94M |
| Breakdown | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 |
| Total cashflows from investing activities | - | -232.30M |
| Total cash from financing activities | 0.00M | 233.55M |
| Net income | 9.12M | 0.38M |
| Change in cash | -0.43M | 0.95M |
| Begin period cash flow | 0.95M | - |
| End period cash flow | 0.52M | 0.95M |
| Total cash from operating activities | -0.43M | -0.30M |
| Issuance of capital stock | 0.00M | - |
| Capital expenditures | 0.00M | 0.00M |
| Change in working capital | 0.14M | -0.19M |
| Other non cash items | -9.54M | -0.49M |
| Free cash flow | -0.43M | -0.30M |
Sector: Financial Services Industry: Shell Companies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| JACS Jackson Acquisition Company II |
- -% |
10.85 | 37.10 | - | - | 1.29 |
| CLUS CLUS |
- -% |
200.00 | - | - | 0.09 | 0.92 |
| SGDH Sgd Holdings Ltd |
- -% |
0.11 | - | - | 59741.55 | 0.56 |
| LION Lionsgate Studios Holding Corp. |
0.05 0.35% |
14.29 | - | 23.31 | 1.13 | 1.35 |
| QKIE QKIE |
0.07 3.72% |
1.95 | - | - | 470.20 | - |
Jackson Acquisition Company II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2024 and is based in Alpharetta, Georgia.
2655 Northwinds Parkway, Alpharetta, GA, United States, 30009
770 643 5605
| Name | Title | Year Born |
|---|---|---|
| Mr. Richard L. Jackson | President, CEO, Chairman | 1955 |
| Mr. David Lawrence M.B.A. | CFO & Treasurer | 1958 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.